08.02.2022 - abc biopply last year’s revenues up more than twice in its strategic core business

Solothurn 08.02.2022 Swiss Biotech Company abc biopply reports revenues in 2021 more than doubled in its core business with its preclinical 3D tumor models. The company has started offering these specialized CRO services to its biotech and pharma clients since 2019. Press Release